Trial Profile
A 24-Week Randomized Double-blind Placebo-Controlled Study Evaluating Efficacy And Safety Of Adalimumab (D2E7)Plus Methotrexate (MTX) In Patients With Active Rheumatoid Arthritis (RA) Despite Treatment With Methotrexate.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2020
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ARMADA
- 12 Aug 2019 Results of post-hoc analysis assessing disease duration and DMARDs affecting response by using data from two studies including this study published in the Annals of the Rheumatic Diseases.
- 01 Jan 2003 New trial record.